95 related articles for article (PubMed ID: 10080425)
1. Maintenance of blood pressure control and left ventricular performance with small doses of enalapril.
González-Juanatey JR; Reino AP; García-Acuña JM; González-Juanatey C; Valdes L; de la Peña MG; Cabezas-Cerrato J
Am J Cardiol; 1999 Mar; 83(5):719-23. PubMed ID: 10080425
[TBL] [Abstract][Full Text] [Related]
2. Step-down of enalapril treatment for arterial hypertension.
González-Juanatey JR; Reino AP; García-Acuña JM; González-Juanatey C; Valdes L; Cabezas-Cerrato J
Hypertension; 1999 Dec; 34(6):1287-92. PubMed ID: 10601132
[TBL] [Abstract][Full Text] [Related]
3. Reduction of QT and QTc dispersion during long-term treatment of systemic hypertension with enalapril.
González-Juanatey JR; García-Acuña JM; Pose A; Varela A; Calvo C; Cabezas-Cerrato J; de la Peña MG
Am J Cardiol; 1998 Jan; 81(2):170-4. PubMed ID: 9591900
[TBL] [Abstract][Full Text] [Related]
4. Long-term effects of losartan and enalapril, alone or with a diuretic, on ambulatory blood pressure and cardiac performance in hypertension: a case-control study.
Verdecchia P; Schillaci G; Reboldi GP; Sacchi N; Bruni B; Benemio G; Porcellati C
Blood Press Monit; 2000 Jun; 5(3):187-93. PubMed ID: 10915233
[TBL] [Abstract][Full Text] [Related]
5. Changes in plasma cardiac natriuretic peptides concentrations during 1 year treatment with angiotensin-converting enzyme inhibitor in elderly hypertensive patients with left ventricular hypertrophy.
Kohno M; Yokokawa K; Yasunari K; Kano H; Minami M; Hanehira T; Yoshikawa J
Int J Clin Pharmacol Ther; 1997 Jan; 35(1):38-42. PubMed ID: 9021441
[TBL] [Abstract][Full Text] [Related]
6. Left ventricular systolic function after marked reduction of ventricular hypertrophy induced by 5 years' enalapril treatment.
González-Juanatey JR; Pose Reino A; García Acuña JM; Castelo Fuentes V; Amaro Gendón A; Calvo Gómez C; Gil de la Peña M
Eur Heart J; 1995 Dec; 16(12):1981-7. PubMed ID: 8682036
[TBL] [Abstract][Full Text] [Related]
7. Differential effects of once-daily antihypertensive drugs on blood pressure, left ventricular mass and sympathetic activity: Nifedipine-GITS versus felodipine-ER versus enalapril.
Leenen FH; Myers MG; Joyner CD; Toal CB
Can J Cardiol; 2002 Dec; 18(12):1285-93. PubMed ID: 12518180
[TBL] [Abstract][Full Text] [Related]
8. Long-term improvement of QT dispersion is unaffected by short-term changes in blood pressure during treatment of systemic hypertension with enalapril.
Seara FJ; Juanatey JR; Sande JL; Veloso PR; Reino AP; Román AV; Cerrato JC; Peña MG
Ann Noninvasive Electrocardiol; 2003 Jan; 8(1):47-54. PubMed ID: 12848813
[TBL] [Abstract][Full Text] [Related]
9. Effects of valsartan on left ventricular diastolic function in patients with mild or moderate essential hypertension: comparison with enalapril.
Cuocolo A; Storto G; Izzo R; Iovino GL; Damiano M; Bertocchi F; Mann J; Trimarco B
J Hypertens; 1999 Dec; 17(12 Pt 1):1759-66. PubMed ID: 10658943
[TBL] [Abstract][Full Text] [Related]
10. Reduction in left ventricular hypertrophy in hypertensive patients treated with enalapril, losartan or the combination of enalapril and losartan.
Avanza AC; El Aouar LM; Mill JG
Arq Bras Cardiol; 2000 Feb; 74(2):103-17. PubMed ID: 10904284
[TBL] [Abstract][Full Text] [Related]
11. An angiotensin-converting enzyme inhibitor improves left ventricular systolic and diastolic function in transfusion-dependent patients with beta-thalassemia major.
Karvounis HI; Zaglavara TA; Parharidis GE; Nouskas IG; Hassapopoulou EP; Gemitzis KD; Louridas GE
Am Heart J; 2001 Feb; 141(2):281. PubMed ID: 11174351
[TBL] [Abstract][Full Text] [Related]
12. Effects of eplerenone, enalapril, and eplerenone/enalapril in patients with essential hypertension and left ventricular hypertrophy: the 4E-left ventricular hypertrophy study.
Pitt B; Reichek N; Willenbrock R; Zannad F; Phillips RA; Roniker B; Kleiman J; Krause S; Burns D; Williams GH
Circulation; 2003 Oct; 108(15):1831-8. PubMed ID: 14517164
[TBL] [Abstract][Full Text] [Related]
13. Effects of ramipril on left ventricular mass and function in cardiovascular patients with controlled blood pressure and with preserved left ventricular ejection fraction: a substudy of the Heart Outcomes Prevention Evaluation (HOPE) Trial.
Lonn E; Shaikholeslami R; Yi Q; Bosch J; Sullivan B; Tanser P; Magi A; Yusuf S
J Am Coll Cardiol; 2004 Jun; 43(12):2200-6. PubMed ID: 15193680
[TBL] [Abstract][Full Text] [Related]
14. Left Ventricular Hypertrophy in Hypertensive Athletes can be Reduced by Antihypertensive Medication Despite Continuing Intense Aerobic Exercise.
Ketelhut S; Franz IW; Ketelhut RG
High Blood Press Cardiovasc Prev; 2018 Dec; 25(4):385-390. PubMed ID: 30341642
[TBL] [Abstract][Full Text] [Related]
15. Cardiovascular structural changes and calcium antagonist therapy in patients with hypertension.
Agabiti-Rosei E; Muiesan ML; Rizzoni D; Zulli R; Calebich S; Castellano M; Cavaliere G; Nordio G; Pasini F; Zuccato F
J Cardiovasc Pharmacol; 1994; 24 Suppl A():S37-43. PubMed ID: 7603076
[TBL] [Abstract][Full Text] [Related]
16. Beta-blockers vs. angiotensin-converting enzyme inhibitors in hypertension: effects on left ventricular hypertrophy.
Gosse P; Roudaut R; Herrero G; Dallocchio M
J Cardiovasc Pharmacol; 1990; 16 Suppl 5():S145-50. PubMed ID: 11527119
[TBL] [Abstract][Full Text] [Related]
17. Reduction of left ventricular mass by short-term antihypertensive treatment with isradipine: a double-blind comparison with enalapril.
Galderisi M; Celentano A; Garofalo M; Tammaro P; Oliviero M; Petrocelli A; de Divitiis O
Int J Clin Pharmacol Ther; 1994 Jun; 32(6):312-6. PubMed ID: 7921533
[TBL] [Abstract][Full Text] [Related]
18. Reduction in left ventricular mass in patients with systemic hypertension treated with enalapril, lisinopril, or fosenopril.
Oren S; Grossman E; Frohlich ED
Am J Cardiol; 1996 Jan; 77(1):93-6. PubMed ID: 8540468
[TBL] [Abstract][Full Text] [Related]
19. ACE inhibitors captopril and enalapril induce regression of left ventricular hypertrophy in hypertensive patients with chronic renal failure.
Dyadyk AI; Bagriy AE; Lebed IA; Yarovaya NF; Schukina EV; Taradin GG
Nephrol Dial Transplant; 1997 May; 12(5):945-51. PubMed ID: 9175047
[TBL] [Abstract][Full Text] [Related]
20. [Effects of renin-angiotensin system blockers on left ventricular hypertrophy and biochemical markers of collagen balance in patients with hypertensive hypertrophy].
Ovchinnikov AG; Serbul VM; Ageev FT
Ter Arkh; 2009; 81(5):64-71. PubMed ID: 19537590
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
